СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ ОБ АУТОИММУННОМ ГЕПАТИТЕ
В статье представлены современные представления о диагностике и лечении аутоиммунного гепатита.
Жумадилова З.К., Муздубаева Ж.Е., Каскабаева А.Ш., Кусаинова А.А.
Государственный медицинский университет города Семей, Казахстан
1. Waldenstrom J. Leber, Blutproteine und Nahrungsei-weiss. Dt Sch Ges Verd Stoffw. 1950; 15: 113-21.
2. Johnson Ph.J., Mc FarlaneI.G. Meeting report: Inter-national Autoimmune Hepatitis Group. Hepatology.1993; 18: 998-1005.
3. Vento S., Garofano T., Di Perri G. et al.Identification of hepatitis A virus as a trigger for autoimmune chronic active hepatitis type 1 in susceptible individuals.Lancet.1991; 337: 1183-7.
4. Rahaman S.M., Chira P., Koff R. S. Idiopatic auto-immune chronic hepatitis triggered by hepatitis A. Am J Gastroenterol. 1994; 89: 106-8
5. Robertson D.A.F., Zhang S.L., Guy E.C., Wright R. Persistent measles virus genome in autoimmune chronic active hepatitis. Lancet.1987; 2: 9-11.
6. Vento S., Guella L., Mirandola F. еtal. Epstein-Barr virus a trigger for autoimmune hepatitis in susceptible indi-viduals. Lancet.1995; 346: 608-9.
7. Garcia-Buey L., Garcia-Monzon C., Rodrigues S. etal. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterolo-gy.1995; 108: 1770-7.
8. Czaja A.J. Autoimmune hepatitis: evolving concepts and treatment strategies. Dig Dis Sci. 1996; 40: 435-56.
9. Johnson Ph. J., Mc Farlane I.G., Williams R. Azathi-oprine for long-term maintenance of remission in autoim-mune hepatitis. N Engl J Med. 1995; 333: 958-63.
10. Nouri-Aria K.T.N., Hegarty J.E., Alexander G.J.M. et al. Effect of corticosteroid on supressor-cell activity in “auto-immune” and viral chronic active hepatitis. N Engl J Med. 1982; 307: 1301-4.
11. Sanchez-Urdazpal L.S., Czaja A.J., van Hock B. et al. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology.1992; 15: 215-21.
12. Stellon A.G., Keating J.J., Johnson Ph. J. et al. Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. Hepatology.1988; 8: 781-4.
13. Feldman M, Friedman L.S, Sleisenger M.H. Gastro-intestinal and Liver Disease, 7th Edition, Saunders 2003, Philadelfia.
14. Czaja A.J, Menon K.V.N, Carpenter H.A. Sustained remission after corticosteroid therapy for autoimmune hepa-titis: a retrospective analysis. Hepatology 2002;35:890–97.
15. Hegarty J.E., Nouri-Aria K.T.N., Portmann B. et al. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis. Hepatolody.1983; 3: 685-89.
16. Vierling J.M, Flores P.A. Evolving new therapies of autoimmune hepatitis.Clin Liver Dis 2002;6:825–50.
17. Alvarez F, Ciocca M., Canero-Velasco C. Short – term cyclosporine induces a remission of autoimmune hep-atitis in children. J Hepatol 1999; 30:222–7.
18. Malekzadeh R., Nasser-Moghaddam S., Kaviani M.J. Cyclosporin–А is a promising alternative to corticosteroids in autoimmune hepatitis. Dig Dis Sci 2001;46:1321–27.
19. Aqel B.A, Machicao V, Rosser B. Efficaсy of tacro-limus in the treatment of steroid refractory autoimmune hepatitis. J Clin Gastroenterol 2004;38:805–09.
20. RichardsonP.D, James P.D, Ryder S.D. Mycophe-nolate mofetil for maintenance of remission in autoimmune hepatitis patients resistant to or intolerant of azathioprine. J Hepatol 2000;33: 371–75.
21. Devlin S.M., Swain M.G., Urbansky S.J. Mycophe-nolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standart therapy. Can J Gastroenterol 2004;18:312–26.
22. Czaja A.J., Carpenter H.A. Empiric therapy of auto-immune hepatitis with mycofenolatе mofetil: comparison with conventional treatment for refractory disease. J Clin Gastroenterol (in press).
23. Czaja A.J., Lindor K.D. Failure of budesonide in a pilot study of treatment – dependent autoimmune hepatitis. Gastroenterology 2000;119: 1312–16.
24. Feldman M., Friedman L.S., Sleisenger M.H. Gas-trointestina land Liver Disease, 7thEdition, Saunders 2003, Philadelfia.
25. Acute and chronic liver diseases: Immunologic mechanisms and therapy. Postgraduate Course of ASLD. 2005, - Р. 139-46.
Количество просмотров: 601
Категория статей:
Статьи
Библиографическая ссылка
Жумадилова З.К., Муздубаева Ж.Е., Каскабаева А.Ш., Кусаинова А.А. СОВРЕМЕННЫЕ ПРЕДСТАВЛЕНИЯ ОБ АУТОИММУННОМ ГЕПАТИТЕ // Наука и Здравоохранение 2014.№ 2. С.42-44 Zhumadilova Z.K., Muzdubayeva Zh.E., Kaskabayeva A.Sh., Kussainova A.A. MODERN CONCEPT OF AUTOIMMUNE HEPATITIS // Nauka i Zdravookhranenie. 2014.№ 2. С. 42-44 Жұмаділова З.К., Муздубаева Ж.Е., Қасқабаева А.Ш., Қусаинова А.А. АУТОИММУНДЫ ГЕПАТИТ ТУРАЛЫ ҚАЗІРГІ КҮНГІ КӨЗҚАРАС // Ғылым және Денсаулық сақтау 2014.№ 2. С. 42-44Похожие публикации:
МЕТОДЫ РАБОТЫ МЕДИЦИНСКИХ СЕСТЕР С ПАЦИЕНТАМИ, ИМЕЮЩИМИ ПОВЕДЕНЧЕСКИЕ ФАКТОРЫ РИСКА (КУРЕНИЕ, АЛКОГОЛЬ): ОБЗОР ЛИТЕРАТУРЫ
ВЗАИМОСВЯЗЬ ИНСУЛИНОРЕЗИСТЕНТНОСТИ И ПОЛИМОРФИЗМОВ ГЕНОВ ЛИПИДНОГО ОБМЕНА И РЕНИН-АНГИОТЕНЗИН-АЛЬДОСТЕРОНОВОЙ СИСТЕМЫ. ОБЗОР ЛИТЕРАТУРЫ
ГЕНЕТИЧЕСКИЕ АСПЕКТЫ ИДИОПАТИЧЕСКОЙ ФОРМЫ ПРИВЫЧНОГО НЕВЫНАШИВАНИЯ БЕРЕМЕННОСТИ. ОБЗОР ЛИТЕРАТУРЫ
Тұжырым НИМЕСУЛИД ҚОЛДАНЫСЫНЫҢ ТИІМДІЛІГІНІҢ САРАПШЫЛЫҒЫ БАС ЖАС ЕМДЕЛУШІЛЕРІНІҢ ДОРСАЛГИЯЛАРМЕН, ОМЫРТҚАНЫҢ ОСТЕОХОНДРОЗЫНЫҢ КЛИНИКАЛЫҚ МАНИФЕСТІМЕН ШАҚЫРТҚАН
EVALUATION OF EFFECTIVENESS OF DICLOBERL® USING AT A HOSPITAL STAGE IN PATIENTS WITH DORSOPATHIES, ACCOMPANIED DORSALGY